Research ArticleCancer

Nuclear Phospho-Akt Increase Predicts Synergy of PI3K Inhibition and Doxorubicin in Breast and Ovarian Cancer

See allHide authors and affiliations

Science Translational Medicine  08 Sep 2010:
Vol. 2, Issue 48, pp. 48ra66
DOI: 10.1126/scitranslmed.3000630

Log in to view PDF

Log in through your institution

Log in through your institution